| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 14110* | 2021 |
| Glycogen synthase kinase 3: an emerging therapeutic target H Eldar-Finkelman Trends in molecular medicine 8 (3), 126-132, 2002 | 524 | 2002 |
| Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action H Eldar-Finkelman, EG Krebs Proceedings of the National Academy of Sciences 94 (18), 9660-9664, 1997 | 429 | 1997 |
| GSK-3 inhibitors: preclinical and clinical focus on CNS H Eldar-Finkelman, A Martinez Frontiers in molecular neuroscience 4, 32, 2011 | 410 | 2011 |
| Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus O Kaidanovich-Beilin, A Milman, A Weizman, CG Pick, H Eldar-Finkelman Biological psychiatry 55 (8), 781-784, 2004 | 351 | 2004 |
| Increased glycogen synthase kinase-3 activity in diabetes-and obesity-prone C57BL/6J mice. H Eldar-Finkelman, SA Schreyer, MM Shinohara, RC LeBoeuf, EG Krebs Diabetes 48 (8), 1662-1666, 1999 | 348 | 1999 |
| Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes AZ Zhao, MM Shinohara, D Huang, M Shimizu, H Eldar-Finkelman, ... Journal of Biological Chemistry 275 (15), 11348-11354, 2000 | 317 | 2000 |
| Inactivation of Glycogen Synthase Kinase-3 by Epidermal Growth Factor Is Mediated by Mitogen-activated Protein Kinase/p90 Ribosomal Protein S6 Kinase Signaling Pathway in NIH … H Eldar-Finkelman, R Seger, JR Vandenheede, EG Krebs Journal of Biological Chemistry 270 (3), 987-990, 1995 | 284 | 1995 |
| Overexpression of mitogen-activated protein kinase kinase (MAPKK) and its mutants in NIH 3T3 cells. Evidence that MAPKK involvement in cellular proliferation is regulated by … R Seger, D Seger, AA Reszka, ES Munar, H Eldar-Finkelman, ... Journal of Biological Chemistry 269 (41), 25699-25709, 1994 | 259 | 1994 |
| Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer … L Avrahami, D Farfara, M Shaham-Kol, R Vassar, D Frenkel, ... Journal of Biological Chemistry 288 (2), 1295-1306, 2013 | 253 | 2013 |
| Increased glucose uptake promotes oxidative stress and PKC-δ activation in adipocytes of obese, insulin-resistant mice I Talior, M Yarkoni, N Bashan, H Eldar-Finkelman American Journal of Physiology-Endocrinology And Metabolism 285 (2), E295-E302, 2003 | 235 | 2003 |
| Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling Z Liberman, H Eldar-Finkelman Journal of Biological Chemistry 280 (6), 4422-4428, 2005 | 226 | 2005 |
| Inhibition of glycogen synthase kinase-3β by bivalent zinc ions: insight into the insulin-mimetic action of zinc R Ilouz, O Kaidanovich, D Gurwitz, H Eldar-Finkelman Biochemical and biophysical research communications 295 (1), 102-106, 2002 | 220 | 2002 |
| Insulin mimetic action of synthetic phosphorylated peptide inhibitors of glycogen synthase kinase-3 B Plotkin, O Kaidanovich, I Talior, H Eldar-Finkelman Journal of Pharmacology and Experimental Therapeutics 305 (3), 974-980, 2003 | 186 | 2003 |
| Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells. H Eldar-Finkelman, GM Argast, O Foord, EH Fischer, EG Krebs Proceedings of the National Academy of Sciences 93 (19), 10228-10233, 1996 | 173 | 1996 |
| PKC-δ-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: role for NADPH oxidase I Talior, T Tennenbaum, T Kuroki, H Eldar-Finkelman American Journal of Physiology-Endocrinology And Metabolism 288 (2), E405-E411, 2005 | 168 | 2005 |
| The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes H Eldar-Finkelman, O Kaidanovich Expert opinion on therapeutic targets 6 (5), 555-561, 2002 | 152 | 2002 |
| Role of glycogen synthase kinase-3β in early depressive behavior induced by mild traumatic brain injury M Shapira, A Licht, A Milman, CG Pick, E Shohami, H Eldar-Finkelman Molecular and Cellular Neuroscience 34 (4), 571-577, 2007 | 141 | 2007 |
| Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle O Kaidanovich-Beilin, H Eldar-Finkelman Journal of Pharmacology and Experimental Therapeutics 316 (1), 17-24, 2006 | 130 | 2006 |
| Nuclear GSK-3β inhibits the canonical Wnt signalling pathway in a β-catenin phosphorylation-independent manner M Caspi, A Zilberberg, H Eldar-Finkelman, R Rosin-Arbesfeld Oncogene 27 (25), 3546-3555, 2008 | 121 | 2008 |